1 / 39

Pandemic H1N1/2009: Virology update

Pandemic H1N1/2009: Virology update. BY Dr Ahmed Morad Asaad M.B.B.Ch , M.Sc , M.D Associate Professor of Microbiology College of Medicine, Najran University. SWINE FLU. Swine flu. Disclaimer: This is JUST FLU !. SWINE FLU paranoia gets out of hands.

mairi
Télécharger la présentation

Pandemic H1N1/2009: Virology update

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Pandemic H1N1/2009: Virology update BY Dr Ahmed MoradAsaadM.B.B.Ch, M.Sc, M.D Associate Professor of Microbiology College of Medicine, Najran University

  2. SWINE FLU Swine flu

  3. Disclaimer: This is JUST FLU! SWINE FLU paranoia gets out of hands

  4. Do not be paranoid about swine flu PARANOIA

  5. Influenza viruses • Classified into types A, B, and C • Types A and B cause significant disease worldwide • Types B and C limited to humans • Type A viruses • More virulent • Wild waterfowl reservoir • Affect many species

  6. Influenza viruses • Members of Orthomyxoviruses family • A single-stranded negative-sense segmented RNA genome Host cell Non-infectious genome Host cell ribosomes RNA-dependant RNA polymerase

  7. Influenza viruses • Members of Orthomyxoviruses family • A single-stranded negative-sense segmented RNA genome Host cell Non-infectious genome Host cell ribosomes RNA-dependant RNA polymerase

  8. Influenza A virus • Pleomorphic enveloped particles 120 nm with spike-like projections C. Goldsmith and A. Balish 2009 • 2 glycoproteins: • Haemagglutinin (H): H1 - H16 • Neuraminidase (N): N1 - N9 • Influenza A subtypes according to combinations of HN types. 144 possible subtypes (16×9). H N C. Goldsmith, 2005

  9. Nomenclature Virus type Type of animal Geographic origin Strain number Year of isolation Virus subtype

  10. Influenza A virus genome - 8 segments - 10 functional proteins Hilleman MR, Vaccine, 3068 – 3087 (2004)

  11. HA NA 1 2 3 4 5 6 7 8 RNA gene segments

  12. Antigenic changes

  13. Antigenic drift • Point mutations in H and/or N • Minor gradual antigenic changes in H & N • Drift mutants will prevail by selective pressure for 2 -5 years PB2 PB1 PA HA HA NP NA NA M1 M2 NS

  14. Antigenic shift • Rearrangement of viral gene segments in cells infected with 2 different viruses (REASSORTMENT) 256 (28) new viruses

  15. Pandemic influenza: The making of a pandemic • A NEW VIRUS Emerges • It causes illness in Humans • It is passes easily person to person • Outbreaks appear worldwide

  16. Emergence of pandemic influenza viruses

  17. Emergence of pandemic influenza viruses

  18. Emergence of pandemic influenza viruses H3N2

  19. Emergence of pandemic influenza viruses H3N2 G Neumann et al.Nature, 1-9 (2009) doi:10.1038/nature08157

  20. Genesis of swine-origin H1N1 influenza viruses

  21. Genesis of swine-origin H1N1 influenza viruses

  22. Genesis of swine-origin H1N1 influenza viruses G Neumann et al.Nature, 1-9 (2009)

  23. H1N1/2009 PB1 PB2 PA H1 NP NS N1 M CDC’s description: “Quadruple” reassortants

  24. H1N1/09 virus: Virulence and pathogenicity Influenza virus host specificity: Haemagglutinin receptor binding specificity (human or avian type receptors) 1 Haemagglutinin cleavage protein: Essential for viral infectivity by mediating fusion between viral envelope and endosomal membrane 2

  25. H1N1/09 virus: Virulence and pathogenicity PB2 protein: Essential for replication of genomic RNA 3 PB1-F2 protein: Induces apoptosis in macrophages, thus down regulating host immune response 4 NS1 protein: Inhibit host interferone 5

  26. H1N1/09 virus: Virulence and pathogenicity • There is a great concern of further mutations (antigenic drift) of the virus which may change its virulence and pathogenicity dramatically .

  27. Seasonal and Pandemic flu vaccines

  28. Seasonal and Pandemic flu vaccines The flu shot vaccine: - Inactivated vaccine (killed virus) - I.M. - People older than 6 months of age The nasal-spray flu vaccine: - Live attenuated virus - Nasal spray - People 2 – 49 years (Not pregnant)

  29. Seasonal and Pandemic flu vaccines

  30. The approved list of vaccines and manufacturers for novel H1N1 influenza: France Australia Switzerland USA

  31. Who?

  32. Pandemic flu vaccines: Concerns & Issues • No long-term safety testing for: • Carcinogenesis • Mutagenesis • Fertility impairment

  33. Pandemic flu vaccines: Concerns & Issues Clinical data at the time when pandemic vaccines are first administered will inevitably be limited. Further testing of safety and effectiveness will need to take place after administration of the vaccine has begun. 8 May 2009

  34. Pandemic flu vaccines: Concerns & Issues

  35. Pandemic flu vaccines: Concerns & Issues

  36. Pandemic flu vaccines: Concerns & Issues

  37. 2009 H1N1 vaccines

  38. “Knowledge is vaccine for swine flu” German Influenza Team For swine flu Paranoia

  39. THANK YOU

More Related